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A B S T R A C T To study the role of gonadotropin-releasing hormone (GnRH) receptors in the regulation of gonadotropin secretion, we used D-'25I-alanine6 des glycyl,0 GnRH ethylamide (D-'251-Ala analog), a nondegradable, superagonist GnRH analog to assess GnRH receptors on rat pituitary membranes. Receptor affinity in intact adult rats was 5.0 x 109 M-l and was unchanged after castration in both sexes. Castration of adult male and female rats produced a twofold increase in GnRH binding capacity by 7 d and binding capacity remained elevated for the subsequent 14 d. GnRH receptor number rose more rapidly after castration in males than females, and the time-course of receptor rise was similar to the increase in serum gonadotropin levels. The increase in GnRH binding capacity was prevented by gonadal steroid replacement at the time of castration in both sexes. Injections ofthe GnRH analog, D-Ser6 (TBu) des Gly,o GnRH ethylamide for 4 d produced a 70%k increase in GnRH receptor number in intact male rats and testosterone-replaced castrates. The same regimen, however, failed to increase the elevated receptor numbers present after castration. Administration of rabbit anti-GnRH serum concomitant with castration inhibited the rise in both GnRH receptor number and luteinizing hormone. The changes in pituitary GnRH receptors parallel previously demonstrated changes in hypothalamic secretion of GnRH. Thus, GnRH probably regulates its own receptor in vivo and gonadal steroids may influence pituitary GnRH receptors by changing hypothalamic GnRH secretion.
INTRODUCTION
Changes in serum gonadotropins after castration and steroid replacement have been extensively documented (1) (2) (3) . However, the precise mechanisms responsible for the gonadotropin rise after castration and the role and relative effects of gonadal steroids at different sites in the hypothalamic-hypophyseal axis have not been completely elucidated. Pituitary secretion of gonadotropins is regulated by gonadotropin-releasing hormone (GnRH)l and gonadal steroids could act on the hypothalamus to change GnRH synthesis and secretion, on the pituitary to modify responsiveness to GnRH, or have effects at both sites. Clear evidence is available that gonadal steroids modulate gonadotropin responses to GnRH in vivo; castration enhances and androgens inhibit gonadotropin secretion following GnRH administration to male rats (4) . Estrogens have a biphasic effect in female rats, initially inhibiting and later enhancing luteinizing hormone (LH) responses to GnRH (5, 6) . Also, gonadotropin secretion after GnRH varies during both the rat estrous cycle (7) (8) (9) (10) (11) and the menstrual cycle in women (12, 13) .
More recent studies (14, 15) have demonstrated increased levels of GnRH in pituitary stalk blood in ovariectomized rhesus monkeys, and this increased GnRH secretion could be responsible for the elevation of gonadotropins after castration. Sarkar et al. (16) found elevated pituitary stalk plasma GnRH concentrations at the time of the proestrus LH surge in rats and the same group recently reported increased GnRH concentrations in pituitary stalk plasma 4 and 28 d following ovariectomy and adrenalectomy (17) . Other studies have shown that orchidectomy reduced and subsequent testosterone or estradiol replacement restored hypothalamic GnRH content to normal in male rats (18) (19) (20) . These data suggest that gonadal steroids influence either hypothalamic synthesis or release ofGnRH. In vitro studies with rat pituitaries or cultured anterior pituitary cells have demonstrated that estrogens enhance (21) (22) (23) and androgens inhibit (23, 24) sensitivity to GnRH.
Changes in pituitary responsiveness to GnRH could be explained in part by changes in GnRH receptor number because GnRH, like other polypeptide hlormones, acts by initially binding to specific receptors on the surface of the target tissue. Thus, factors such as gonadal steroids that influence pituitary responsiveness to GnRH could conceivably exert their action by altering the number of receptors for GnRH on the surface of the gonadotroph (25) .
Previous studies (26-28) using native GnRH as ligand have demonstrated the presence of two GnRH binding sites, one with high capacity but low affinity, and another with high affinity and low capacity that probably represents the physiologically important GnRH receptqr. Since most of the binding is to the low affinity site, changes in characteristics of the high affinity site were difficult to measure accurately (25) . In this study, we assessed pituitary GnRH receptors using a superagonist GnRH analog, D-alanine6 des glycyl,0 GnRH ethylamide (D-Ala analog) as ligand. We have previously demonstrated that the D-Ala analog binas to a single class of receptors that apparently are the same sites involved in the high affinity interaction with GnRH (29) . In addition, superagonist GnRH analogs are resistant to degradation by pituitary membranes and cytosol (30) , and thus use of the D-Ala analog avoids the problems oftracer degradation seen with native GnRH (31) .
The following studies were performed to delineate changes in the number and affinity of pituitary membrane GnRH (32) . Rabbit antiGnRH serum (33) and normal rabbit serum were kindly provided by Dr. R. P. Kelch. Bovine serum albumin (BSA) was obtained from Miles Laboratories, Inc., Elkhart, Ind. All other chemicals were of reagent quality.
Adult Holtzman rats weighing 225-250 g were maintained on a 14-h light/10-h dark cycle and allowed free access to food and water. Rats were castrated under ether and methoxyflurane anesthesia. Control animals were anesthetized, sham operated, and killed in an identical manner to castrated rats. In studies of steroid replacement, silastic implants filled with crystalline testosterone or estradiol were implanted subcutaneously at the time of castration. Two implants, 0.062 in. ID and 0.0125 in. OD and 10.5 mm in length were used for each animal. Details of the timing of different manipulations are given in Results.
After decapitation, pituitary glands were removed and the anterior pituitary was placed in 0.25 M sucrose, frozen in ethanol-dry ice, and stored at -85°C before use in the binding assay. For use in a binding study, pituitaries were thawed on ice and homogenized by hand in 0.25 M sucrose using a ground glass homogenizer (10 strokes). The homogenate was centrifuged at 300 g for 5 min at 4°C, and the resulting supernate centrifuged at 10,800 g for 20 min. The 10,800 g pellet was washed three times in 10 mM Tris buffer, and then resuspended to a dilution of 100 ,ug protein/ml. 200 ,ul of this crude membrane preparation was added to BSA-precoated polypropylene tubes containing assay buffer ( The total incubation volume was 500 ,ul. After preliminary studies showed that binding was maximal at 40-60 min, the assay mixture was incubated for 1 h at 4°C. Receptor bound hormone was separated by centrifugation at 27,000 g for 15 min at 4°C. The supemate was aspirated and the pellet counted. Using this system and membranes from intact rats, 8-15% of added tracer was bound in the absence of unlabeled hormone. Nonspecific binding was assessed in the presence of 20 ng of unlabeled hormone and was 1.5-2% oftotal added counts. Determination of protein content of the membrane preparation was performed by the method of Lowry (34) . Receptor (36) . Testosterone and estradiol were measured by radioimmunoassay as previously described (37, 38 The specific activity of D-'25I-Ala analog was assessed by self-displacement in a radioreceptor assay. Binding of serial dilutions of tracer alone was parallel to that using small amounts of tracer (15 pg) and increasing amounts of unlabeled hormone. The specific activity of D-1251-Ala analog was determined for each tracer preparation and ranged from 740 to 1,300 ,uCi/,g (calculated using 100% of added counts).
The specificity of analog binding to the pituitary membrane preparation is shown in Fig. 1 FIGuRE 4 Time-course of changes in serum gonadotropins and GnRH binding capacity after castration in adult male rats (Mean±SE; n = 8 at each time point; *P < 0.05; **P < 0.0001) in the left panel, and in adult females castrated on estrus or diestrus in the right panel (n = 4; *P < 0.05; **P < 0.005).
BSA-injected castrate animals with steroid replacement had lower GnRH binding capacity than intact rats given BSA injections (P < 0.05).
Serum LH was 14.1±2.6 and 19.6±3.7 ng/ml for intact rats treated with BSA and D-Ser analog (=NS); 460±69 and 315±38 for castrated rats, (=NS); and 9.3 ±1.9 and 7.6±1.4 for testosterone replace castrates (=NS).
In additional studies, rabbit anti-GnRH serum M-13 was administered to adult male rats at the time of castration. It has previously been reported that this antibody is specific for amino acids 4-10 of native GnRH and that 0.5 ml of the antisera has a binding capacity for GnRH of 4.3 ,gg/ml (33) . Antisera and normal rabbit serum were diluted with equal volumes of saline and 0.5 ml was given intraperitoneally at the time of castration at 0800 hours on day 1. Subsequently, 0.25 ml was injected intraperitoneally at 0800 hours on days 2-4 and again 10 h before death on the morning of day 5. The results shown in Fig. 7 (18) (19) (20) . In the experiment shown in Fig. 5 , serum testosterone was lower 14 d after castration and testosterone replacement probably due to diminished testosterone release from the implant. At this time, serum LH was elevated and GnRH binding capacity was also increased to values intermediate between intact and castrate levels. This suggests that the lower serum testosterone may have resulted in increased hypothalamic GnRH secretion which, in turn, could have induced the increase in GnRH receptor number.
In conclusion, we have described a method to assess pituitary membrane GnRH receptors, and using this system we have demonstrated increased GnRH receptor number following castration and treatment with a superagonist GnRH analog. The observed changes in GnRH receptor number correlate well with previous studies of pituitary responsiveness to GnRH. Our data are consistent with endogenous GnRH positively regulating its own receptor. The effects of gonadal steroids on GnRH receptor number may be mediated by changes in GnRH secretion. At the present time, however, direct effects of gonadal steroids on the pitui- 
